Breaking News
1 day ago
Vaibhavi M.

Jupiter Neurosciences adds former White House Council of Economic Advisers Acting Chairman Dr. Tomas Philipson to its board, effective June 26, 2026.
Vaibhavi M.

Realbotix, Onconetix's pending acquisition target, launches a UK humanoid robot pilot with Bloom Procurement Services for elderly care settings.
Vaibhavi M.

Celea Therapeutics raises $180M to launch SURPASS-IPF, the first head-to-head Phase 3 trial in idiopathic pulmonary fibrosis, targeting Q3 2026.
Vaibhavi M.

EMA's CHMP opens phased review of Revolution Medicines' daraxonrasib, setting a procedural template for sequenced dossier submissions under reformed EU legislation.
Vaibhavi M.
